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Mass spectrometry and gas phase ion mobility [gas phase electrophoretic macromolecule
analyzer (GEMMA)] with electrospray ionization were used to characterize the structure of the
noncovalent 28-subunit 20S proteasome from Methanosarcina thermophila and rabbit. ESI-MS
measurements with a quadrupole time-of-flight analyzer of the 192 kDa 7-ring and the intact
690 kDa 7777 are consistent with their expected stoichiometries. Collisionally activated
dissociation of the 20S gas phase complex yields loss of individual -subunits only, and it is
generally consistent with the known 7777 architecture. The analysis of the binding of a
reversible inhibitor to the 20S proteasome shows the expected stoichiometry of one inhibitor
for each -subunit. Ion mobility measurements of the 7-ring and the 7777 complex yield
electrophoretic diameters of 10.9 and 15.1 nm, respectively; these dimensions are similar to
those measured by crystallographic methods. Sequestration of multiple apo-myoglobin
substrates by a lactacystin-inhibited 20S proteasome is demonstrated by GEMMA experi-
ments. This study suggests that many elements of the gas phase structure of large protein
complexes are preserved upon desolvation, and that methods such as mass spectrometry and
ion mobility analysis can reveal structural details of the solution protein complex. (J Am Soc
Mass Spectrom 2005, 16, 998–1008) © 2005 American Society for Mass SpectrometryThe structural determination of protein complexescan play an important role in the fundamentalunderstanding of biochemical pathways. “Every
major process in a cell is carried out by assemblies of 10
or more protein molecules . . . .The entire cell can be
viewed as a factory that contains an elaborate network
of interlocking assembly lines, each of which is com-
posed of a set of large protein machines [1].” Francis
Collins of the National Human Genome Research Insti-
tute states that “genes and gene products do not func-
tion independently, but participate in complex, inter-
connected pathways, networks, and molecular systems
that, taken together, give rise to the workings of cells,
tissues, organs, and organisms. Defining these systems
and determining their properties and interactions is
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doi:10.1016/j.jasms.2005.02.017crucial to understanding how biological systems func-
tion [2].” Proteins interact both nonspecifically and
specifically; however, the specific interactions are im-
portant because of the downstream consequences they
can presage. These consequences include inducing a
change in the structure of an interaction partner, stabi-
lizing or destabilizing an interaction partner, modifying
the activity of a protein (activate, inhibit, or otherwise
regulate), causing an interaction partner to move to
another location, cutting an interaction partner, and
chemically modifying an interaction partner (i.e., post-
translational modification).
With information from the Human Genome Project
comes a new revolution in proteomics [3], in which
researchers are trying to determine how genes function
within the genome and how they communicate with
each other. These efforts may lead to important new
insights into disease mechanisms and improved drug
discovery strategies. The proteome is the protein com-
plement to the genome. To study protein function on a
r Inc. Received December 13, 2004
Revised February 14, 2005
Accepted February 14, 2005
999J Am Soc Mass Spectrom 2005, 16, 998–1008 ESI-MS AND ION MOBILITY OF THE 20S PROTEASOMEwide scale, methods are being developed to identify the
locations of proteins, their cellular levels, their struc-
tures, how they are modified, and their interactions
with other proteins [4]. The development of new bio-
analytical tools, such as mass spectrometry (MS), to
view large assemblies can have a profound role in the
functional understanding of a protein.
Techniques based on mass spectrometry and gas
phase methods have been developed to facilitate the
characterization of the proteome and its protein assem-
blies. Specifically, from the initial pioneering develop-
ment of electrospray ionization (ESI) by 2002 Nobelist
John Fenn [5], the application of ESI-MS for studying
noncovalent complexes has utility in biology, biochem-
istry, and biomedical research [6 – 8]. The ability of
electrospray to preserve elements of the native structure
directly results from the gentleness of the overall
method, i.e., dissociation of the ESI-generated gas phase
complex is minimal. The determination of molecular
mass can be used to augment the study of macromolec-
ular assemblies and their individual components. The
molecular mass measurement provides a direct readout
of the stoichiometry of the binding partners in the
complex, even for multi-ligand hetero-complexes. For
many cases investigated by ESI-MS, the complex stoi-
chiometry for the gas phase complex is consistent with
that expected for the solution phase complex [9, 10].
The mass spectrometry method requires the promo-
tion of the solution phase protein complex to the
gaseous state. Several studies have suggested that some
higher order elements of the solution phase structure
are preserved in the dehydrated complex [11]. In gen-
eral, a high correlation has been found between ESI-MS
data and expectations based on solution phase results
[6]. MS has not progressed to the stage to address
whether the precise three-dimensional structure of the
gas phase molecule or complex is the same as the
solvated species. However, some structural elements
may be preserved upon transition to the gaseous state.
The physical characteristics of the gas phase complex,
such as their dissociation behavior and their topograph-
ical features, are consistent with information gathered
from other biophysical experiments designed to probe
the solution complex. Collision cross-section measure-
ments by ESI-ion mobility and ion scattering measure-
ments [12–14], hydrogen-deuterium exchange studies,
and blackbody infrared dissociation (BIRD) experi-
ments [15] have suggested that different gas phase
protein conformers can be measured. Studies of a virus
or an enzyme collected post-ESI mass spectrometry
demonstrated that the ESI and desolvation processes
are not destructive, as the biological molecules re-
mained bioactive after exposure to vacuum. However,
they do not indicate directly the structure of the gas
phase (or solution phase) complex [16, 17]. Robinson
and coworkers have provided numerous examples of
collisionally activated dissociation (CAD) of large pro-
tein complexes; many of the examples, including the
ribosome, found consistency between the known stabil-ities of the solution complex and the dissociative behav-
ior of gas phase noncovalent complexes. They have
been able to differentiate electrostatic and hydrophobic
contributions to the structural stability of protein com-
plexes [7, 18, 19]. In one case from our laboratory, the
tertiary geometry of a cyclic polypeptide was probed by
CAD; its CAD behavior suggested that noncovalent
interactions necessary to maintain its three dimensional
structure is preserved in its gas phase molecule [20].
A primary advantage of MS-based methods is the
ability to study the intrinsic factors related to protein
stability not related to solvation and hydration. The
forces involved with protein hydration that enhance
protein complex stability may not be necessary for its
stability in the gas phase. How the solventless environ-
ment affects the ability of mass spectrometry to probe
the solution characteristics of large biomolecules is a
central question. Can the measurement of gas phase
molecules be related to the original solution phase?
What is the fidelity between the gas phase and solution
structure? In general, the strongest correlations for the
ESI-MS experiments to the solution phase are found in
the stoichiometry measurements and the observed rel-
ative abundances. But a close correspondence between
the expected mass and the measured mass of the
complex does not ensure fidelity of the structure of the
complex.
There have been relatively few studies that have
compared directly the physical geometric size of
electrospray-generated gas phase protein complexes
with the data obtained by other structural tools, such as
X-ray crystallography and NMR [21]. A number of very
large protein complexes have been measured by ESI-MS
[6, 8, 9]. Because of its high sensitivity and moderate
resolution at very high m/z (e.g., above m/z 6000), the
time-of-flight (TOF) analyzer provides an ideal system
for large noncovalent complexes, and it is considered
the standard system today for such analyses. Standing
and coworkers first demonstrated its potential for large
protein complexes by measuring ESI mass spectra of
soybean agglutinin and a variety of other protein sys-
tems [22]. Among the largest complex measured by
ESI-MS is the 2.5 MDa bacteriophage MS2 virus capsid
composed of 180 copies of the viral coat protein [23].
Several other reports of complexes in excess of 500 kDa
have been described [24], including the 800 kDa chap-
eronin GroEL 14-mer assembly [25] and the intact 850
kDa 30S subunit of the E. coli ribosome, composed of 21
protein components and the 16S RNA molecule [18].
Heck and coworkers have measured mass spectra for
the 0.5 MDa octamer, 1.0 MDa octamer-dimer, and 1.5
MDa octamer-trimer complexes of the vanillyl-alcohol
oxidase enzyme [26] and the H. pylori urease complex of
1.06 MDa [27].
We have analyzed the 690 kDa 20S proteasome
complex by ESI-MS and by gas phase ion mobility
analysis coupled with charge-neutralized electrospray
and compared the results to their crystallographically-
derived dimensions [28]. The proteasome is a multicata-
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cytoplasm of all eukaryotic cells [29, 30]. The protea-
some is a recycler of damaged, misfolded, and short-
lived regulatory proteins, and it is of critical importance
to cell cycle and cell survival. It is the central enzyme of
nonlysosomal protein degradation (i.e., the ubiquitin-
proteasome pathway). Because the proteasome cleaves
numerous cell cycle regulators, antigenic proteins, and
transcription factors, it is an attractive target for the
development of drugs for the treatment of cancer,
autoimmune diseases, inflammation, and other patho-
logical states [31]. Currently, competitive inhibitors of
proteasome activity are in clinical trials involving mul-
tiple cancers and stroke. The 2004 Nobel Prize in
Chemistry was awarded to Aaron Ciechanover, Avram
Hershko, and Irwin Rose for their elucidation of regu-
lated protein degradation by the proteasome. The
unique structure of the 20S proteasome allowed for
comparison of its gas phase properties, including reac-
tivity with small molecule inhibitors, with its known
solution features.
Experimental
A nanoESI-QqTOF analyzer (QSTAR Pulsar XL, m/z
range 40,000; Applied Biosystems/MDS Sciex, Con-
cord, ON, Canada) was used for the ESI-MS experi-
ments with the -subunit proteasome [32]. A prototype
QqTOF analyzer optimized for MS and MS/MS of large
molecular weight protein complexes previously de-
scribed was used for the analysis of the intact 20S
proteasome [33]. Borosilicate glass nanospray emitters
that are coated with Au/Pd to allow for 10–50 nL/min
spray operation were obtained from Proxeon (Odense,
Denmark).
For the ion mobility experiments, a gas phase electro-
phoretic mobility macromolecule analyzer (GEMMA,
Model 3890, TSI Inc., Shoreview, MN) was used. The
details of the GEMMA instrumentation and method for
measuring protein size have been described elsewhere
[34 –36]. Briefly, the GEMMA instrument consists of an
electrospray ionization unit with a neutralizing chamber,
a differential mobility analyzer (DMA) and a condensa-
tion particle counter (CPC). Multiply charged droplets
generated by electrospray are charge reduced by interac-
tion with ions formed by -radiation (210Po). The droplets
ultimately evaporate, leaving macromolecular ions of low
charge as residues [37]. The singly charged ions pass
through a scanning differential mobility analyzer and are
counted by a condensation particle counter. An electrical
mobility diameter is measured as a result of the ion
mobility analysis. Protein solutions are introduced via the
ESI source at a flow rate of approximately 70 nl/min. Each
sample concentration was run at least three times. Protein
solutions for the ESI-MS experiments were 1–10 M, and
1 nM (in 10 mM ammonium acetate, pH 7.5) for the
GEMMA experiments. Solutions were desalted and con-
centrated by centrifugal filtration using Microcon or Ami-con Ultra-4 filters (Millipore, Bedford, MA) for both the
ESI-MS and GEMMA experiments.
For the binding reaction of lactacystin to the 20S
proteasome, 2 L of 1.55 M 20S proteasome was
added to 2 L of 0.5 nmol/L lactacystin. A solution of
20 mM ammonium acetate, pH 7.5 was added to the
sample to bring the total volume to 30 L. The solution
was incubated at 37 °C. Matrix-assisted laser desorp-
tion/ionization (MALDI)-MS experiments were per-
formed with a Voyager DE-STR TOF analyzer (Applied
Biosystems, Foster City, CA). For the protein
MALDI-MS measurements, sinapinic acid was used as
the matrix.
The Methanosarcina thermophila 20S proteasome,
-subunit, lactacystin, and ALLN were obtained from
Calbiochem (San Diego, CA). The 20S proteasome from
rabbit and equine apo-myoglobin was obtained from
Sigma Chemicals (St. Louis, MO).
Results and Discussion
ESI-MS and Collisionally Activated Dissociation
of the 20S Proteasome
The 20S proteasome enzyme is a giant assembly of
multiple subunits [38]. Its 28 subunits of the 20S cata-
lytic core are arranged into four stacked rings, each
containing seven subunits. The outer -rings contain
only noncatalytic -subunits, whereas each of the two
inner -rings harbor three active centers concealed
inside the barrel-like structure with the N-terminal Thr
residues as the catalytic centers. The 20S particle with
attached two 19S complexes forms the complete 26S
proteasome responsible for recognition and degrada-
tion of proteins tagged with polyubiquitin chains [39].
The first crystal structures of the 20S proteasome were
from archeae systems, showing the 7777 stoichiom-
etry in which each of the -subunits and each of the
-subunit are identical [40]. Initial studies of mamma-
lian proteasomes show similar architecture, with differ-
ences in the size of the internal cavity; mammalian
proteasomes show a more closed cavity, with its open-
ing regulated by substrate introduction and the activity
of the 19S assembly [41].
ESI-MS of the -subunit from archaeon Methanosar-
cina thermophila under pH 7.5 native solution conditions
shows a molecular mass of 191.9 kDa (Figure 1a),
consistent with the expected value (191.9 kDa) for a
heptameric 7 complex [42]. ESI-MS of the full 7777
20S proteasome from M. thermophila yields a molecular
mass of approximately 690.5 kDa (theory 689.3 kDa)
with multiply charged ions found at m/z 11,000 (Figure
2a). Other lower abundance protein clusters are ob-
served at higher m/z. Ions representing a 20S dimer (or
2 times 7777) molecule of 1.39 MDa are found atm/z
14,000–16,000. These are likely to be formed from
nonspecific aggregation of the 20S species in solution
and/or in the gas phase, as previous structural studies
have not identified an active, native 20S dimer. Another
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12,000–13,500 and centered at 80 charges; molecular
mass measurements indicate a size of approximately
1.02 MDa. The closest theoretical composition to match
the experimentally measured value is a complex with a
stoichiometry of 7 (77)2 7, or 14 28. Similar to the
observed 20S dimer, a 14 28 species is not consistent
with any known proteasome architecture. However, it
is difficult to rationalize the formation of the 14 28
complex as nonspecific gas phase aggregation. The
-subunit nor the 7-ring are not observed to dissociate
from the 20S proteasome in solution nor in the gas
phase (vide infra). It is believed that association of the
-subunit to form the 20S complex requires its direct
association with the -subunit, or perhaps with the
7-ring complex [43]. By itself, the -subunit will not
assemble into an aggregate (7) in solution.
The dissociation of the gas phase proteasome com-
plexes yields data that is similar to studies for other
protein complexes. In general, collisionally activated
dissociation of a large multiply charged complex held
together through noncovalent bonding yields a liber-
ated monomer (or a few subunits) and the remaining,
much larger complex (minus the liberated molecule).
Furthermore, the distribution of charge in the products
is not evenly distributed. Jurchen and Williams have
reported that the asymmetric charge distribution results
from unfolding of the monomer product, thus exhibit-
ing a more flexible conformation [44]. CAD of the
33-charged precursor ion for the 7 complex shows
loss of 1 to form an 6 complex (Figure 1b). However,
the free 1 retains up to 22 charges, or approximately
67% of the total charge, although it accounts for only
14% of the mass of the original 7 complex. Likewise,
Figure 1. (a) ESI-MS of the -subunit from a
molecules for the 192 kDa 7 noncovalent comp
yields the 1 and 6 products.the CAD-spectrum of the 63-charged 20S proteasomegenerates the free 1 subunit with 15-28 charges and
the remaining 7776 molecule with 35-44 charges
(Figure 3). The 1 molecule retains approximately one-
third of the total charge available onto a molecule that
accounts for only 4% of the mass, presumably because it
is liberated in more of an unfolded state than the
remaining 7776 complex.
Moreover, dissociation of the gas phase 20S complex
generates product ions up to m/z 35,000 from the loss of
only the -subunits, consistent with the known structure
of the 7777 complex. This is depicted in Figure 2b,
showing the CAD-spectrum generated by increasing the
orifice potential from 100V to 300V and inducing protein
fragmentation in the atmosphere-vacuum interface. The
loss of one and two 27.4 kDa -subunits is observed; the
loss of 21.8 kDa -subunits was not observed under these
experimental conditions. The isoelectric points of the sub-
units are not sufficiently different (i.e., pI of the -subunit
is 5.2 and the -subunit pI is 6.6) to suggest their different
gas phase behavior. Based on a 7777 geometry, the
loss of the outer -subunits would be favored more
compared to loss of the internal -subunits because of the
reduced number of potential intermolecular protein-
protein contacts.
The ESI-MS/MS studies of the 20S proteasome
from M. thermophila represent a near ideal situation
because each of the seven -subunits of the 7-ring
and the seven -subunits 7-ring are identical. The
situation for 20S proteasomes from higher order
species is not as simple, as each of the 7 -subunits
and seven -subunits are different, and additional
heterogeneity may occur from potential post-transla-
tional modifications, such as phosphorylation. This is
reflected in the ESI mass spectrum acquired under
on M. thermophila, showing multiply charged
b) ESI-MS/MS of the 33-charged 7 precursorrchae
lex. (denaturing solution conditions of the 20S proteasome
77
1002 LOO ET AL. J Am Soc Mass Spectrom 2005, 16, 998–1008from rabbit (Figure 4b). (However, it is not possible at
present to assign each subunit to a molecular mass
because the amino acid sequences for the rabbit
proteasome subunits are not available.) The ESI mass
spectrum acquired under native solution conditions
of the rabbit 20S complex shows a relatively hetero-
geneous distribution of peaks in the m/z 10,000–
12,000 range that reflects a molecular mass of approx-
imately 698 kDa (Figure 5a). A more accurate
Figure 2. (a) ESI-MS of the M. thermophila 77
of 100 V. Expansions are shown for the intact
and a 20S hybrid complex (1.02 MDa). (b) ESI-M
300 V. Dissociation in the atmosphere/vacu
liberated 27.4 kDa -subunit and the remainingFigure 3. ESI-MS/MS of the 63-charged 777measurement is difficult because of peak broadness.
CAD of the rabbit 20S complex shows peak distribu-
tions similar to the M. thermophila 20S proteasome,
suggesting that the loss of one and two -subunits are
the preferred dissociation pathways (Figure 5b).
However, the low sensitivity and the broad peaks
preclude any judgement on the identity of the disso-
ciated -subunits at present.
The ESI mass spectra of the 20S proteasome were
28-mer 20S proteasome with an orifice potential
omplex (690 kDa), the 20S “dimer” (1.39 MDa),
the 20S proteasome with the orifice potential of
interface of the 7777 complex yields the
76 (or 13 14) and 12 14 complexes.77
20S c
S of
um7 28-mer 20S proteasome from M. thermophila.
it.
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cent reports have shown that transmission of high mass
ions requires pressures in the first vacuum stages of the
mass spectrometer to be increased [19, 24, 45, 46].
Krutchinsky et al. have suggested that larger ions may
acquire substantial kinetic energies (of more than 1000
eV) when they are sprayed out of the supersonic jet [24].
It is now widely accepted that a combination of colli-
sional cooling and focusing of the ions and more
efficient desolvation is effective for enhanced detection
of ions with high m/z values. Recently, a prototype
ESI-QqTOF system has been built with improved sen-
sitivity for very large protein complexes [33]. Improve-
ments in sensitivity for large protein complexes appear
to derive from improved cooling and focusing in Q0
produced by raising the pressure in this region. No
Figure 4. Deconvoluted ESI mass spectra of d
acetic acid) from (a) M. thermophila and (b) rabb
Figure 5. ESI-MS mass spectra of rabbit 20S pro
potential of (a) 100 V and (b) 350 V.benefits from increasing the pressure in the nozzle-
skimmer region, as observed for orthogonal “Z-spray”
interfaces [46], were observed. Compared with the
commercially-available QqTOF mass spectrometer, the
prototype QqTOF has a sensitivity gain range from tens
to thousands for very large complexes (greater than 0.5
MDa).
ESI-MS of Inhibitor Binding
to the 20S Proteasome
ESI mass spectrometry has been applied to the binding
of small molecular weight inhibitors to their macromo-
lecular targets, including proteins [47, 48] and nucleic
acids [49]. The noncovalent binding of small molecule
red 20S proteasomes (50% acetonitrile with 1%
me (10 mM ammonium acetate) with an orificeenatuteaso
1004 LOO ET AL. J Am Soc Mass Spectrom 2005, 16, 998–1008inhibitors can be readily measured by ESI-MS, and this
strategy can be applied to screen libraries of potential
drugs for the pharmaceutical industry. We attempted to
measure the binding stoichiometry of the reversible
aldehyde inhibitor ALLN (Ac-Leu-Leu-Nle-CHO, Mr
383.5) to the M. thermophila 20S proteasome by ESI-MS.
Protease activity of the proteasome is inhibited by
molecules that bind to the interior surface formed by
the two 7-rings of the complex. The x-ray crystal
structure of the 20S proteasome in complex with ALLN
shows binding to each -subunit [40]. The ESI mass
spectra of the 20S-ALLN complex shows a molecular
mass increase of 5410 Da (5369 Da expected) that is
consistent for the binding of 14 ALLN molecules (or 1
molecule per -subunit) to form a noncovalent complex
composed of 42 entities (7777-ALLN14) (Figure 6).
The dissociation of the gas phase protein-inhibitor
complex shows a stepwise release of bound inhibitor
molecules. Increasing the orifice potential from 150 to
350 V induces the loss of one and two -subunits,
similar to that shown in Figure 2b. Starting from the
7777-ALLN14 complex, the 13 14 complex from
the loss of one -subunit shows a molecular mass of
approximately 665.5 kDa compared to 662.5 kDa for the
7777 as the starting material (Figure 2b); this would
be consistent for 10 ALLN molecules bound to 13 14,
or the loss of 4 out of 14 bound ALLN. Generation of the
12 14 complex from the loss of two -subunits is
accompanied by the release of all 14 ALLN molecules
(Mr 635.0 kDa; see Figure 2b for comparison).
The CAD behavior of the 20S proteasome is consis-
tent for the architecture of the 7777 solution com-
plex, as the loss of the -subunit is preferred. Moreover,
the binding stoichiometry of up to 14 molecules of
ALLN is consistent for the known specificity of the
inhibitor to the -subunits. However, it is not clear
whether the loss of two -subunits originates from the
same 7-ring, i.e., 7776 and 7775, or if the
origins of the lost -subunits are from the opposing
7-rings (i.e., 7776 and 6776). The dissociation
of 4 and 10 molecules of ALLN upon the removal of one
Figure 6. Deconvoluted ESI mass spectra of the M. thermophila
20S proteasome (left) before and (right) after addition of excess
reversible aldehyde inhibitor ALLN (Ac-Leu-Leu-Nle-CHO, Mr
383.5).and two -subunits, respectively, may favor slightly the
hypothesis that only one of the 7-rings is involved. If a
stepwise mechanism is invoked, the loss of the initial
-subunit may impart a preferred activation site for the
second dissociation event. This may be reflected by the
ALLN behavior, as the bulk of the inhibitor molecules
are lost after only 4 molecules are lost in the initial
event. One may expect an equal number of ALLN
molecules being lost for each -subunit if they originate
from opposite 7-rings. However, much more experi-
mental data is needed to support either mechanism.
ESI-Ion Mobility of the 20 Proteasome
To extend our measurements towards even greater
sized protein complexes, we are exploring the use of a
gas phase electrophoretic mobility molecular analyzer
(GEMMA) [34, 50, 51]. The GEMMA utilizes a differen-
tial mobility analyzer to measure gas phase electro-
phoretic mobility (EM) that is proportional to the elec-
trophoretic diameter of the particle. The GEMMA offers
utility for the characterization of proteins, glycopro-
teins, protein aggregates, high-mass noncovalent pro-
tein complexes, whole viruses, and nanoparticles of
biological importance [34 –36]. For GEMMA, the biomo-
lecular complexes are electrosprayed followed by
charge neutralization of the evaporating droplets to
generate primarily neutral and singly charged mole-
cules. Alpha particles generated by a 210Po source ionize
gas molecules in the atmosphere, producing reactive
species such as H, H3O
, (H2O)nH3O
, O2
, NO, O2
,
NO2
, OCN, etc. These primary species quickly form
ionized clusters 1–2 nm in size, chiefly with water
molecules. The clusters diffuse to the evaporating drop-
lets, causing their charge distribution to approach a
distribution centered about zero charge. When the
droplets have evaporated completely, the distribution
consists almost entirely of neutral macromolecules and
singly charged macroions. The singly charged proteins
are separated according to their EMs in air, and their
mobilities are interpreted in terms of an “electro-
phoretic mobility diameter” (EM diameter) of the gas
phase protein.
Although the electrophoretic mobility of a particle is
governed by its size and shape, this method has been
used also to characterize proteins and noncovalently-
bound protein complexes, showing a correlation be-
tween the experimentally derived electrophoretic mo-
bility diameter and its predicted mass. The resolving
power of the device is relatively low, no larger than 20
in terms of the EM diameter, but this does not preclude
the utility of the GEMMA measurement for large pro-
teins, especially when the many charge states of ESI-MS
are unresolved [34]. Mass measurements are based on a
simple model relating molecular weight to the diameter
of a sphere and an effective density. From the GEMMA
measurements by our laboratory (manuscript in prep-
aration) and from those reported by Bacher et al. [34] for
over 40 protein complexes ranging in size from small
red
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viral particles, an effective density of approximately 0.6
g/cm3 can be used to estimate the molecular masses of
proteins.
GEMMA experiments with nondenaturing pH 7.5
solutions of the 7-ring and the full 20S proteasome
from M. thermophila yielded diameters of the gas phase
molecules of 10.9 nm and 15.1 nm, respectively (Figure
7). The crystal structures of the 20S proteasome barrel
for nearly all of the species measured to date show a
width of 11.3 nm and a length of 14.8 nm, with a pore
diameter of 13 Å. The GEMMA data suggests the
general preservation of the solution phase structure or
size upon desolvation, but there appears to be a slight
decrease in GEMMA-measured protein size of approx-
imately 10–20% compared with solution phase mea-
surements. This is consistent with ion mobility-TOF
measurements by Counterman and Clemmer for indi-
vidual amino acid residues [21]. The average volumes
of amino acids were determined to be 5–20% smaller
than their corresponding values determined from crys-
tallographic data.
To explore further the utility of the GEMMAmethod
for protein complex analysis, the measurement of a
trapped protein substrate by the 20S proteasome was
attempted. As suggested by Dunn and coworkers [52],
a potential protein substrate can be trapped within a
proteasome core without proteolysis by using an irre-
versible proteasome inhibitor. Lactacystin binds specif-
ically to Thr-1 of the -subunit in a covalent manner to
impart protease inhibition of the 20S proteasome. Apo-
myoglobin is partially disordered and “unfolded” at
pH 7.5 to enter the barrel of the 20S proteasome.
Proteolysis occurs and peptide fragments of 8–10 amino
acids in length are generated (unpublished data). The
protease activity of lactacystin-bound 20S proteasome is
completely inhibited. Figure 8 shows the reactivity of
lactacystin to the 20S complex. Each -subunit is co-
Figure 7. ESI-GEMMA of the 7 and 7777
structure (right) shows the dimensions as measuvalently bound with one molecule of lactacystin within4 h at pH 8.0, 37 °C. The GEMMA measurement of the
20S-lactacystin complex shows a broad peak centered at
15.2 nm (Figure 9); this represents a slight increase from
the 15.1 nm diameter for the apo-form of the 20S
complex (see Figure 7). A mass increase of 2940 Da
(210 Da for each of 14 -subunits) would show only a
slight increase in electrophoretic mobility diameter.
Incubation of excess apo-myoglobin (Mr 16951) with
20S-lactacystin produces a larger complex centered at
15.7 nm. This translates to a molecular mass increase of
approximately 76.3 kDa, or 4.5 molecules of apo-
roteasome complexes from M. thermophila. The
by X-ray crystallography.
Figure 8. MALDI-TOF mass spectra of the -subunit and -subunit20S preactivity with lactacystin at times (a) zero, (b) 1 h, and (c) 4 h.
1006 LOO ET AL. J Am Soc Mass Spectrom 2005, 16, 998–1008myoglobin. ESI-QqTOF mass spectra of the protea-
some-lactacystin-myoglobin complex showed only a
very broad, unresolved peak. From the GEMMA data, it
appears that a distribution of myoglobin molecules is
trapped by the inhibited proteasome. Although a pre-
vious study suggested that a single protein substrate, 12
kDa cytochrome c, can be sequestered intact in an
inhibited proteasome complex, the heme group of cy-
tochrome c was found to form a “knot” that could
sterically hinder substrate processing [52]. Apo-
myoglobin, lacking the heme group, may be less steri-
cally hindered from entering the 20S proteasome even
from both ends of the complex. Moreover, up to three
adjacent -strands in a hairpin configuration in a single
protein can fit through each -annulus [53]. However,
more experiments are necessary to interpret our
GEMMA data on substrate binding to the proteasome.
Conclusions
Our ESI-MS and GEMMA analysis of the 20S proteasome
from archeon Methanosarcina thermophila demonstrates
their ability to measure the mass and size of the intact
noncovalent complex. The electrospray-based experi-
ments suggest that the majority of the structure of the gas
phase molecule is very similar to that found for its
solution phase counterpart. The forces that relate to pro-
tein hydration and maintain complexes in solution may
not be necessary for their overall stability in the gas phase.
The experiments do not address whether the more refined
details in protein secondary structure are retained upon
the transition to the gaseous state. However, the close
correspondence between the size of the gas phase protea-
some and their crystal structures suggests that the gross
Figure 9. ESI-GEMMA of the 20S-lactacystin c
exposure to excess equine apo-myoglobin (15.7 n
addition of apo-myoglobin suggests that the unf
complex.features of the large protein complexes remain upondehydration. Further work will continue to explore the
fidelity of the gas phase measurement and the solution
phase structure of the proteasome and other large protein
complexes. It is likely that tools based on measurement of
the gas phase macromolecule will be complementary to
large-scale efforts in structural biology to determine the
structure of all biologically important proteins and
complexes [54].
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